Journal of Oral and Maxillofacial Surgery
Volume 68, Issue 3 , Pages 508-514 , March 2010

Characteristics of Implant Failures in Patients With a History of Oral Bisphosphonate Therapy

  • Daniel C. Martin, DDS

      Affiliations

    • Former Resident, Division of Maxillofacial Surgery, Kaiser Permanente, Oakland Medical Center, Oakland, CA, and Department of Oral and Maxillofacial Surgery, Highland General Hospital, Oakland, CA; and Currently, Private Practice, Truckee, CA
    • ,
  • Felice S. O'Ryan, DDS

      Affiliations

    • Director, Division of Maxillofacial Surgery, Kaiser Permanente, Oakland Medical Center, Oakland, CA
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr O'Ryan: Kaiser Permanente Division of Maxillofacial Surgery, 280 W MacArthur Blvd, Oakland, CA 94611
    • ,
  • A. Thomas Indresano, DMD

      Affiliations

    • Chairman, Department of Oral and Maxillofacial Surgery, Highland General Hospital, Oakland, CA
    • ,
  • Pete Bogdanos

      Affiliations

    • Research Associate, Division of Research, Kaiser Permanente Northern California, Oakland, CA
    • ,
  • Benjamin Wang

      Affiliations

    • Research Intern, Division of Research, Kaiser Permanente Northern California, Oakland, CA
    • ,
  • Rita L. Hui, PharmD, MS

      Affiliations

    • Outcomes Research Scientist, Pharmacy Outcomes Research Group, Drug Information Services, Kaiser Permanente, California, Oakland, CA
    • ,
  • Joan C. Lo, MD

      Affiliations

    • Research Scientist and Senior Physician, Division of Research, Kaiser Permanente Northern California, Oakland, CA

References 

  1. Rodan GA, Reszka AA. Bisphosphonate mechanism of action. Curr Mol Med. 2002;2:571
  2. Marx RE, Sawatari Y, Fortin M, et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63:1567
  3. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 2004;62:527
  4. Woo SB, Hellstein JW, Kalmar JR. Narrative (corrected) review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753
  5. Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 Update. J Oral Maxillofac Surg. 2009;67:2
  6. Marx RE, Cillo JE, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397
  7. Mavrokokki T, Cheng A, Stein B, et al. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007;65:415
  8. Lo JC, O'Ryan FS, Gordon NP, et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010;68:243
  9. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol. 2006;24:945
  10. Jadu F, Lee L, Pharoah M, et al. A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients. Ann Oncol. 2007;18:2015
  11. Pozzi S, Marcheselli R, Sacchi S, et al. Bisphosphonate-associated osteonecrosis of the jaw: A review of 35 cases and an evaluation of its frequency in multiple myeloma patients. Leuk Lymph. 2007;48:56
  12. Walter C, Al-Nawas B, du Bois A, et al. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients. Cancer. 2009;115:1631
  13. Wang EP, Kaban LB, Strewler GJ, et al. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg. 2007;65:1328
  14. Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report. Int J Oral Maxillofac Implants. 1995;10:74
  15. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: Literature review and a case report. J Periodontol. 2007;78:584
  16. Brooks JK, Gilson AJ, Sindler AJ, et al. Osteonecrosis of the jaws associated with use of risedronate: Report of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:780
  17. Shabestari GO, Shayesteh YS, Khojasteh A, et al. Implant placement in patients with oral bisphosphonate therapy: A case series. Clin Implant Dent Relat Res. Apr 23, 2009;[Epub ahead of print]
  18. Fugazzotto PA, Lightfoot WS, Jaffin R, et al. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol. 2007;78:1664
  19. Grant BT, Amenedo C, Freeman K, et al. Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases. J Oral Maxillofac Surg. 2008;66:223
  20. Jeffcoat MK. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants. 2006;21:349
  21. Elad S, Yarom N, Khamaisi M: Re: Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and the incidence of complications in two private practices. Fugazzoto PA, Lightfoot WS, Jaffin R, et al. J Periodontol 78:1664, 2007. J Periodontol 2008:584, author reply: 5
  22. Kasai T, Pogrel MA, Hossaini M. The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc. 2009;37:39
  23. Dodson TB, Chuang SK. Frequency estimates of Bron—Is it really zero?. J Oral Maxillofac Surg. 2008;66:1558;author reply; 9
  24. Blazsek J, Dobo Nagy C, Blazsek I, et al. Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model. Pathol Oncol Res. Mar 7, 2009;[Epub ahead of print]
  25. Berardi D, Carlesi T, Rossi F, et al. Potential applications of bisphosphonates in dental surgical implants. Int J Immunopathol Pharmacol. 2007;20:455
  26. Duarte PM, de Vasconcelos Gurgel BC, Sallum AW, et al. Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats. J Periodontol. 2005;76:107
  27. Aspenberg P. Bisphosphonates and implants: An overview. Acta Orthop. 2009;80:119
  28. Viera-Negron YE, Ruan WH, Winger JN, et al. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone. J Oral Implantol. 2008;34:76
  29. Gao Y, Luo E, Hu J, et al. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats. Bone. 2009;44:225
  30. Bell BM, Bell RE. Oral bisphosphonates and dental implants: A retrospective study. J Oral Maxillofac Surg. 2008;66:1022
  31. American Association of Oral and Maxillofacial Surgeons. Position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369
  32. Esposito M, Hirsch JM, Lekholm U, et al. Biological factors contributing to failures of osseointegrated oral implants ((II). Etiopathogenesis). Eur J Oral Sci. 1998;106:721
  33. Esposito M, Hirsch JM, Lekholm U, et al. Biological factors contributing to failures of osseointegrated oral implants ((I). Success criteria and epidemiology). Eur J Oral Sci. 1998;106:527
  34. Moy PK, Medina D, Shetty V, et al. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants. 2005;20:569
  35. Roos-Jansaker AM, Lindahl C, Renvert H, et al. Fourteen-year follow-up of implant treatment (Part I: Implant loss and associations to various factors). J Clin Periodontol. 2006;33:283
  36. Minsk L, Polson AM. Dental implant outcomes in postmenopausal women undergoing hormone replacement. Compend Contin Educ Dent. 1998;19:859;64
  37. Sverzut AT, Stabile GA, de Moraes M, et al. The influence of tobacco on early dental implant failure. J Oral Maxillofac Surg. 2008;66:1004
  38. van Steenberghe D, Naert I, Jacobs R, et al. Influence of inflammatory reactions vs. occlusal loading on peri-implant marginal bone level. Adv Dent Res. 1999;13:130
  39. Branemark PI, Adell R, Albrektsson T, et al. Osseointegrated titanium fixtures in the treatment of edentulousness. Biomaterials. 1983;4:25
  40. Snauwaert K, Duyck J, van Steenberghe D, et al. Time dependent failure rate and marginal bone loss of implant supported prostheses: A 15-year follow-up study. Clin Oral Investig. 2000;4:13
  41. Del Fabbro M, Testori T, Francetti L, et al. Systematic review of survival rates for immediately loaded dental implants. Int J Periodontics Restorative Dent. 2006;26:249
  42. Chuang SK, Wei LJ, Douglass CW, et al. Risk factors for dental implant failure: A strategy for the analysis of clustered failure-time observations. J Dent Res. 2002;81:572
  43. Weyant RJ, Burt BA. An assessment of survival rates and within-patient clustering of failures for endosseous oral implants. J Dent Res. 1993;72:2
  44. Rosenberg ES, Torosian JP, Slots J. Microbial differences in 2 clinically distinct types of failures of osseointegrated implants. Clin Oral Implants Res. 1991;2:135
  45. August M, Chung K, Chang Y, et al. Influence of estrogen status on endosseous implant osseointegration. J Oral Maxillofac Surg. 2001;59:1285;discussion: 90

 This study was funded by the US Food and Drug Administration (HHSF223200510008C), the National Institute of Child Health and Human Development at the National Institutes of Health (K12 HD052163), and the Kaiser Permanente Community Benefit Program. A portion of this study was also supported by the National Center for Research Resources at the National Institutes of Health (UCSF-CTSI UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the Food and Drug Administration or the National Institutes of Health.

PII: S0278-2391(09)01759-5

doi: 10.1016/j.joms.2009.09.055

Journal of Oral and Maxillofacial Surgery
Volume 68, Issue 3 , Pages 508-514 , March 2010

Article Tools